ArchiMed invests in Xpress Biologics

  • by


ArchiMed has invested in plasmid DNA and protein therapeutics developer Xpress Biologics, with the intention of implementing a tenfold production capacity increase for the company.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *